Inhibition of Growth Hormone Receptor Activation by Pegvisomant may Increase Bone Density in Acromegaly

2010 ◽  
Vol 43 (01) ◽  
pp. 55-61 ◽  
Author(s):  
C. Jimenez ◽  
M. Ayala-Ramirez ◽  
J. Liu ◽  
R. Nunez ◽  
R. F. Gagel
Endocrinology ◽  
1999 ◽  
Vol 140 (12) ◽  
pp. 5505-5515 ◽  
Author(s):  
Yilei Mao ◽  
Pei-Ra Ling ◽  
Timothy P. Fitzgibbons ◽  
Karen C. McCowen ◽  
G. Peter Frick ◽  
...  

2005 ◽  
Vol 12 (9) ◽  
pp. 814-821 ◽  
Author(s):  
Richard J Brown ◽  
Julian J Adams ◽  
Rebecca A Pelekanos ◽  
Yu Wan ◽  
William J McKinstry ◽  
...  

JMS SKIMS ◽  
2017 ◽  
Vol 20 (2) ◽  
pp. 104-106
Author(s):  
Javaid Ahmad Bhat ◽  
Moomin Hussain Bhat ◽  
Hilal Bhat ◽  
Mona Sood ◽  
Shariq Rashid Masoodi

Background : Laron & colleagues (1966) reported a rare genetic disorder in Israliei Jewish sublings which was characterized by insensitivity to growth hormone due to abnormality in growth hormone receptor or post receptor signaling pathway.Case Report: We hereby report a case of a 5 year old female child who presented to us with features similar to Laron syndrome. The diagnosis was made & confirmed by various Lab. investigations like low IGF-I levels and managed accordingly. JMS 2017; 20 (2):104-106  


2019 ◽  
Author(s):  
Emily Cottrell ◽  
Avinaash Maharaj ◽  
Tasneem Ladha ◽  
Sumana Chatterjee ◽  
Anna Grandone ◽  
...  

2002 ◽  
Vol 68 (sup1) ◽  
pp. 959-960 ◽  
Author(s):  
YUICHI OZAKI ◽  
HARUHISA FUKADA ◽  
YUKINORI KAZETO ◽  
SHINJI ADACHI ◽  
AKIHIKO HARA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document